Current Report Filing (8-k)
June 02 2017 - 4:50PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 19, 2017
Ethema Health Corporation
(Exact name of registrant as specified in its
charter)
Colorado
|
000-15078
|
84-1227328
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
5734
Yonge Street, Suite 300
Toronto,
Ontario, Canada M2M 4E7
|
(Address
of principal executive offices)
|
(416)
222-5501
|
(Registrant’s
telephone number, including area code)
|
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[
]
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
[
]
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
1.02 Termination of a Material Definitive Agreement.
On May 26, 2017 the Company
repaid Labrys Fund LP $112,724.38 US, retiring a convertible note (the "Note") payable to Labrys Fund LLP. The Note
was issued on F
ebruary 2, 2017, in the principal amount of USD$110,000.00, bearing annual
interest at 8% and maturing on August 2, 2017. In connection with the payoff of the Note, Labrys returned 1,200,000 shares of
common stock of the Company which were being held by the lender in escrow. The escrowed shares were returned to treasury.
Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
On April 19, 2017, Eileen
Greene (“Greene”), wife of CEO Shawn Greene, advanced four hundred thousand and 00/100 Canadian dollars ($400,000.00
CDN) to Ethema Health Corporation (the “Company”) as a short term loan. The loan is interest free and there are no
fixed terms of repayment. The funds were used for working capital purposes and to repay corporate debt. The Company expects to
repay this loan from proceeds of a mortgage refinancing that it intends to complete on its Canadian property in the very near
future. On May 23, 2017 the Company sold a 25% share of a $700,000 CDN second mortgage that is registered against the Company's
Canadian property to Yonge - McNairn Corporation Limited for net proceeds of $147,620.27. Yonge - McNairn Corporation Limited
already owned 50% of the mortgage.
Item 3.02 Unregistered Sales of Equity
Securities.
On May 31, 2017 the Company
settled a Consultant invoice of $5,000 US with the issuance of 100,000 restricted shares of Company common stock at the rate of
$0.05 per share. The shares have been issued.
In making the Consultant
Issuance, Consultant made representations to the Company that he individually met the accredited investor definition of Rule 501
of the Securities Act, and the Company relied on such representations. The Consultant Issuance were offered and sold without registration
under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule
506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.
The Consultant Issuance
was not conducted in connection with a public offering, and no public solicitation or advertisement was made or relied upon by
the Consultant in connection with the offering. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation
of an offer to buy, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption
from the registration requirements.
[signature
page follows]
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
Date:
June 2, 2017
By:
/s/ Shawn E. Leon
Name:
Shawn E. Leon
Title: CEO
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Sep 2023 to Sep 2024